The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

Muhammad O Awiwi,1 Khaled M Elsayes,1 Yehia I Mohamed,2 Lina Altameemi,2 Migena Gjoni,3 Omayr Muhammad Irshad,4 Ahmed Sayed Ahmed,5 Ahmad O Kaseb,2 Usama Salem1 1Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Department of Medical Oncology, Th...

Full description

Bibliographic Details
Main Authors: Awiwi MO, Elsayes KM, Mohamed YI, Altameemi L, Gjoni M, Irshad OM, Sayed Ahmed A, Kaseb AO, Salem U
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
radiographic
radiology
recist
survival
neutrophil-to-lymphocyte ratio
platelet-to-lymphocyte ratio.
Online Access:https://www.dovepress.com/the-prognostic-value-of-baseline-clinical-and-radiologic-imaging-featu-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/the-prognostic-value-of-baseline-clinical-and-radiologic-imaging-featu-peer-reviewed-fulltext-article-JHC

Similar Items